BIP Wealth LLC increased its stake in Johnson & Johnson shares by 55.4% during the third quarter, acquiring an additional 3,948 shares to hold a total of 11,073 shares at period end. The firm’s holdings were valued at approximately $2.05 million, reflecting a strategic belief in the company’s long-term growth prospects. This move contrasts with several smaller institutional shifts: Evolution Wealth Management initiated a position worth $27,000 in the second quarter, Clayton Financial Group added $28,000 in the third quarter, and Signature Resources Capital Management more than tripled its exposure to 254 shares, valued at $47,000. Overall, institutional and hedge fund ownership stands at 69.6%, underscoring broad confidence among professional investors.

Research firms have collectively maintained a favorable stance on Johnson & Johnson, with one analyst assigning a strong buy, sixteen endorsing a buy recommendation, and nine issuing hold ratings. Citigroup raised its target from $232 to $250 and reiterated a buy rating, while Guggenheim increased its target from $227 to $240. Raymond James lifted its objective from $174 to $209, converting its view to 'outperform.' Loop Capital and Freedom Capital set targets at $190 and held their ratings respectively. The consensus price target among these analysts stands at $226.18, indicating upside potential from current levels and supporting a ‘Moderate Buy’ consensus summary.

In its latest quarterly report, Johnson & Johnson delivered earnings per share of $2.46 on revenues of $24.56 billion, matching consensus EPS estimates and exceeding top-line forecasts by $420 million. Revenue growth of 9.1% year-over-year was driven by strength in both pharmaceuticals and medical devices. The company projects full-year 2026 EPS in the range of $11.43 to $11.63, while free cash flow is anticipated to rise toward $21 billion, reflecting disciplined capital allocation and operational leverage. Management also declared a quarterly dividend of $1.30 per share, translating to an annualized yield of 2.4% and maintaining a payout ratio of roughly 47%, reinforcing its reputation for steady income distribution.